Literature DB >> 19622391

Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders.

Mark P Mattson1.   

Abstract

A rising tide of obesity and type 2 diabetes has resulted from the development of technologies that have made inexpensive high calorie foods readily available and exercise unnecessary for many people. Obesity and the metabolic syndrome (insulin resistance, visceral adiposity and dyslipidemia) wreak havoc on cells throughout the body thereby promoting cardiovascular and kidney disease, and degenerative diseases of the brain and body. Obesity and insulin resistance promote disease by increasing oxidative damage to proteins, lipids and DNA as the result of a combination of increased free radical production and an impaired ability of cells to detoxify the radicals and repair damaged molecules. By covalently modifying membrane-associated proteins, the membrane lipid peroxidation product 4-hydroxynonenal (HNE) may play particularly sinister roles in the metabolic syndrome and associated disease processes. HNE can damage pancreatic beta cells and can impair the ability of muscle and liver cells to respond to insulin. HNE may promote atherosclerosis by modifying lipoproteins and can cause cardiac cell damage by impairing metabolic enzymes. An adverse role for HNE in the brain in obesity and the metabolic syndrome is suggested by studies showing that HNE levels are increased in brain cells with aging and Alzheimer's disease. HNE can cause the dysfunction and degeneration of neurons by modifying membrane-associated glucose and glutamate transporters, ion-motive ATPases, enzymes involved in amyloid metabolism, and cytoskeletal proteins. Exercise and dietary energy restriction reduce HNE production and may also increase cellular systems for HNE detoxification including glutathione and oxidoreductases. The recent development of low molecular weight molecules that scavenge HNE suggests that HNE can be targeted in the design of drugs for the treatment of obesity, the metabolic syndrome, and associated disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622391      PMCID: PMC2753676          DOI: 10.1016/j.exger.2009.07.003

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  134 in total

Review 1.  The metabolic syndrome and cerebrovascular disease: suspicion and evidence.

Authors:  Antonio Gil-Núñez
Journal:  Cerebrovasc Dis       Date:  2007-11-01       Impact factor: 2.762

Review 2.  Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis.

Authors:  Ignazio Grattagliano; Vincenzo O Palmieri; Piero Portincasa; Antonio Moschetta; Giuseppe Palasciano
Journal:  J Nutr Biochem       Date:  2007-09-12       Impact factor: 6.048

3.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

4.  Role of cardiac glutathione transferase and of the glutathione S-conjugate export system in biotransformation of 4-hydroxynonenal in the heart.

Authors:  T Ishikawa; H Esterbauer; H Sies
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

5.  Production of lipid peroxidation products in osteoarthritic tissues: new evidence linking 4-hydroxynonenal to cartilage degradation.

Authors:  Barbara Morquette; Qin Shi; Patrick Lavigne; Pierre Ranger; Julio C Fernandes; Mohamed Benderdour
Journal:  Arthritis Rheum       Date:  2006-01

6.  Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice.

Authors:  Alexis M Stranahan; Kim Lee; Bronwen Martin; Stuart Maudsley; Erin Golden; Roy G Cutler; Mark P Mattson
Journal:  Hippocampus       Date:  2009-10       Impact factor: 3.899

7.  Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men.

Authors:  C Xiao; A Giacca; G F Lewis
Journal:  Diabetologia       Date:  2007-11-17       Impact factor: 10.122

8.  beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger.

Authors:  A J Bruce; B Malfroy; M Baudry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

9.  4-hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition.

Authors:  W Liu; A A Akhand; M Kato; I Yokoyama; T Miyata; K Kurokawa; K Uchida; I Nakashima
Journal:  J Cell Sci       Date:  1999-07       Impact factor: 5.285

10.  Low-density lipoprotein has an enormous capacity to bind (E)-4-hydroxynon-2-enal (HNE): detection and characterization of lysyl and histidyl adducts containing multiple molecules of HNE.

Authors:  Suresh P Annangudi; Yijun Deng; Xiaorong Gu; Wujuan Zhang; John W Crabb; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2008-06-21       Impact factor: 3.739

View more
  106 in total

Review 1.  Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart.

Authors:  Ethan J Anderson; Lalage A Katunga; Monte S Willis
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-02       Impact factor: 2.557

2.  Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model.

Authors:  Reilly T Enos; Kandy T Velázquez; Jamie L McClellan; Taryn L Cranford; Michael D Walla; E Angela Murphy
Journal:  Nutr Res       Date:  2015-04-11       Impact factor: 3.315

3.  Comparison of N-methyl-D-aspartate receptor subunit 1 and 4-hydroxynonenal in the hippocampus of natural and chemical-induced aging accelerated mice.

Authors:  Sung Min Nam; Tae-Ho Chung; Jong Whi Kim; Hyo Young Jung; Hee Seon Yim; Dae Won Kim; Dae Young Yoo; Hajin Nam; Jung Hoon Choi; In Koo Hwang; Jun-Gyo Suh; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2014-07-15       Impact factor: 3.996

Review 4.  Intake of ω-6 Polyunsaturated Fatty Acid-Rich Vegetable Oils and Risk of Lifestyle Diseases.

Authors:  Tetsumori Yamashima; Tsuguhito Ota; Eishiro Mizukoshi; Hiroyuki Nakamura; Yasuhiko Yamamoto; Mitsuru Kikuchi; Tatsuya Yamashita; Shuichi Kaneko
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

5.  Age-associated alterations in the levels of cytotoxic lipid molecular species and oxidative stress in the murine thymus are reduced by growth hormone treatment.

Authors:  Valeria de Mello-Coelho; Roy G Cutler; Allyson Bunbury; Anita Tammara; Mark P Mattson; Dennis D Taub
Journal:  Mech Ageing Dev       Date:  2017-09-01       Impact factor: 5.432

6.  4-Hydroxy-2(E)-nonenal (HNE) catabolism and formation of HNE adducts are modulated by β oxidation of fatty acids in the isolated rat heart.

Authors:  Qingling Li; Sushabhan Sadhukhan; Jessica M Berthiaume; Rafael A Ibarra; Hui Tang; Shuang Deng; Eric Hamilton; Laura E Nagy; Gregory P Tochtrop; Guo-Fang Zhang
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

Review 7.  The neuropathology of obesity: insights from human disease.

Authors:  Edward B Lee; Mark P Mattson
Journal:  Acta Neuropathol       Date:  2013-10-06       Impact factor: 17.088

Review 8.  Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance.

Authors:  S Dalleau; M Baradat; F Guéraud; L Huc
Journal:  Cell Death Differ       Date:  2013-10-04       Impact factor: 15.828

Review 9.  Oxidative stress and protein carbonylation in adipose tissue - implications for insulin resistance and diabetes mellitus.

Authors:  Tatjana Ruskovska; David A Bernlohr
Journal:  J Proteomics       Date:  2013-04-11       Impact factor: 4.044

10.  Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits.

Authors:  Jim R Fadel; Lawrence P Reagan
Journal:  Curr Opin Behav Sci       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.